Settlement date

DSM - delivery of shares

Retrieved on:

Tuesday, April 25, 2023

HEERLEN, Netherlands, April 25, 2023 /PRNewswire/ -- Following the Offering Circular published on 22 November 2022, DSM and DSM-Firmenich are required to announce transactions in relation to the ordinary shares in their respective share capital in accordance with the Dutch public offer rules.

Key Points:

With reference to the Offering Circular (in particular sections 11.16 (Long-term incentive plans) and 13.7 (Principal terms of the Business Combination Agreement)), DSM has during the Acceptance Period tendered in the Exchange Offer 662,616 DSM ordinary Shares held in treasury in order to be able to fulfill its obligations under the respective DSM Incentive Plans after the Settlement Date.
Upon Settlement, DSM received 662,616 DSM-Firmenich Ordinary shares in exchange for the aforementioned DSM Ordinary Shares tendered in the Exchange Offer.
As a result, DSM held a total of 640,228 (instead of 635,176) DSM-Firmenich ordinary shares on 24 April 2023.
At the date hereof, DSM holds a total of 640,078 DSM-Firmenich ordinary shares (in order to be able to fulfill its obligations under the respective DSM Incentive Plans), representing approximately 0.4246% of the DSM-Firmenich ordinary shares.

DSM - delivery of shares

Retrieved on:

Monday, April 24, 2023

Section 17 of the Constitution Act, 1867, Exercise, DSM, Nutrition, File, Settlement date, Section 13, Exchange, Business analyst, DSM (company), Settlement, Animal, Euronext Amsterdam, Offering circular, Principal, Exchange offer, Security (finance), Pharmaceutical industry, Health

HEERLEN, Netherlands, April 24, 2023 /PRNewswire/ -- Following the Offering Circular published on 22 November 2022, DSM and DSM-Firmenich are required to announce transactions in relation to the ordinary shares in their respective share capital in accordance with the Dutch public offer rules.

Key Points:

With reference to the Offering Circular (in particular sections 11.16 (Long-term incentive plans) and 13.7 (Principal terms of the Business Combination Agreement)), DSM has during the Acceptance Period tendered in the Exchange Offer 662,616 DSM ordinary Shares held in treasury in order to be able to fulfill its obligations under the respective DSM Incentive Plans after the Settlement Date.
Upon Settlement, DSM received 662,616 DSM-Firmenich Ordinary shares in exchange for the aforementioned DSM Ordinary Shares tendered in the Exchange Offer.
Pursuant to commitments entered into prior to issuing the Offering Circular, DSM has on 24 April 2023 delivered 14,139 DSM-Firmenich ordinary shares to employees in view of (i) settling the vesting of 8,474 share units granted under the respective DSM Incentive Plan and (ii) settling the exercise of 5,665 stock options granted under the respective DSM Incentive Plan (average exercise price €61.92).
At the date hereof, DSM holds a total of 635,176 DSM-Firmenich ordinary shares (in order to be able to fulfill its obligations under the respective DSM Incentive Plans), representing approximately 0.4214% of the DSM-Firmenich ordinary shares.

DSM - delivery of shares

Retrieved on:

Friday, April 21, 2023

Section 17 of the Constitution Act, 1867, Exercise, DSM, Nutrition, File, Settlement date, Section 13, Exchange, Business analyst, Settlement, Animal, Offering circular, Principal, Exchange offer, Security (finance), Health

HEERLEN, Netherlands, April 21, 2023 /PRNewswire/ -- Following the Offering Circular published on 22 November 2022, DSM and DSM-Firmenich are required to announce transactions in relation to the ordinary shares in their respective share capital in accordance with the Dutch public offer rules.

Key Points:

With reference to the Offering Circular (in particular sections 11.16 (Long-term incentive plans) and 13.7 (Principal terms of the Business Combination Agreement)), DSM has during the Acceptance Period tendered in the Exchange Offer 662,616 DSM Ordinary Shares held in treasury in order to be able to fulfill its obligations under the respective DSM Incentive Plans after the Settlement Date.
Upon Settlement, DSM received 662,616 DSM-Firmenich Ordinary shares in exchange for the aforementioned DSM Ordinary Shares tendered in the Exchange Offer.
Pursuant to commitments entered into prior to issuing the Offering Circular, DSM has on 21 April 2023 delivered 825 DSM-Firmenich ordinary shares to employees in view of settling the exercise of 825 stock options granted under the respective DSM Incentive Plan (average exercise price €87.13).
At the date hereof, DSM holds a total of 649,315 DSM-Firmenich ordinary shares (in order to be able to fulfill its obligations under the respective DSM Incentive Plans), representing approximately 0.4307% of the DSM-Firmenich ordinary shares.

DSM - delivery of shares

Retrieved on:

Thursday, April 20, 2023

Section 17 of the Constitution Act, 1867, Exercise, DSM, Nutrition, File, Settlement date, Section 13, Exchange, Business analyst, DSM (company), Animal, Euronext Amsterdam, Offering circular, Principal, Exchange offer, Security (finance), Health

HEERLEN, Netherlands, April 20, 2023 /PRNewswire/ -- Following the Offering Circular published on 22 November 2022, DSM and DSM-Firmenich are required to announce transactions in relation to the ordinary shares in their respective share capital in accordance with the Dutch public offer rules.

Key Points:

With reference to the Offering Circular (in particular sections 11.16 (Long-term incentive plans) and 13.7 (Principal terms of the Business Combination Agreement)), DSM has during the Acceptance Period tendered in the Exchange Offer 662,616 DSM Ordinary Shares held in treasury in order to be able to fulfill its obligations under the respective DSM Incentive Plans after the Settlement Date.
As a result of the Settlement that took place today, DSM received 662,616 DSM-Firmenich ordinary shares in exchange for the aforementioned DSM Ordinary Shares tendered in the Exchange Offer.
Pursuant to commitments entered into prior to issuing the Offering Circular, DSM has on 20 April 2023 delivered 4,680 DSM-Firmenich ordinary shares to employees in view of settling the exercise of 4,680 stock options granted under the respective DSM Incentive Plan (average exercise price €58.16).
At the date hereof, DSM holds a total of 650,140 DSM-Firmenich ordinary shares (in order to be able to fulfill its obligations under the respective DSM Incentive Plans), representing approximately 0.43% of the DSM-Firmenich ordinary shares.

EXCHANGE OFFER DECLARED UNCONDITIONAL

Retrieved on:

Monday, April 17, 2023

KAISERAUGST, Switzerland and HEERLEN, Netherlands and GENEVA, April 17, 2023 /PRNewswire/ --

Key Points:

After settlement of the Post-Closing Acceptance Period, the Company intends to implement either the Buy-Out or the Post-Offer Merger and Liquidation
DSM and Firmenich boards are very pleased to announce that the Company hereby declares the Exchange Offer unconditional.
As a result, the Exchange Offer will be settled on 20 April 2023 and the Firmenich Contribution will occur on 8 May 2023.
This announcement contains selected, condensed information regarding the Exchange Offer and does not replace the Offering Circular.
Accordingly, to be eligible to receive DSM-Firmenich Ordinary Shares under the Exchange Offer, each DSM Shareholder that is a U.S.

EXCHANGE OFFER DECLARED UNCONDITIONAL

Retrieved on:

Monday, April 17, 2023

DSM and Firmenich boards are very pleased to announce that the Company hereby declares the Exchange Offer unconditional.

Key Points:

DSM and Firmenich boards are very pleased to announce that the Company hereby declares the Exchange Offer unconditional.
As a result, the Exchange Offer will be settled on 20 April 2023 and the Firmenich Contribution will occur on 8 May 2023.
This announcement contains selected, condensed information regarding the Exchange Offer and does not replace the Offering Circular.
Accordingly, to be eligible to receive DSM-Firmenich Ordinary Shares under the Exchange Offer, each DSM Shareholder that is a U.S.

WeWork Announces Early Tender Results of the Exchange Offers and Consent Solicitations and Changes to the Late Exchange Consideration

Retrieved on:

Monday, April 17, 2023

No consideration will be paid for Consents in the Consent Solicitations (each as defined in the Offering Memorandum).

Key Points:

No consideration will be paid for Consents in the Consent Solicitations (each as defined in the Offering Memorandum).
Shares of Class A Common Stock delivered as part of the Exchange Consideration will be rounded down to the nearest whole share.
Subject to the tender acceptance procedures described in the Offering Memorandum, Eligible Holders who validly tender Old Notes after the Early Exchange Time and before the Expiration Time will receive the Late Exchange Consideration, which will be the same as the Early Exchange Consideration, as further described in the Offering Memorandum.
The Company has engaged PJT Partners LP as the dealer manager (the “Dealer Manager”) for the Exchange Offers and Consent Solicitations.

2023 put option event notice

Retrieved on:

Wednesday, April 5, 2023

In accordance with Condition 6(e)(ii) and Condition 6(e)(2) (2023 Put Option) of each respective Series of Notes, the Issuer hereby gives notice to the holders of the Notes (each a “Holder” and together the “Holders”) that the Amendment Effective Date occurred on 4 April 2023 and, accordingly, the 2023 Put Option Period shall commence today, 5 April 2023, and expire at 5:00 p.m. (New York time) on 19 April 2023.

Key Points:

In accordance with Condition 6(e)(ii) and Condition 6(e)(2) (2023 Put Option) of each respective Series of Notes, the Issuer hereby gives notice to the holders of the Notes (each a “Holder” and together the “Holders”) that the Amendment Effective Date occurred on 4 April 2023 and, accordingly, the 2023 Put Option Period shall commence today, 5 April 2023, and expire at 5:00 p.m. (New York time) on 19 April 2023.
For the avoidance of doubt, the 2023 Put Option Election Notice defined in this notice is the 2023 Put Option Election Notice referred to in the Conditions and Holders do not need to obtain any form of notice from the Settlement Agent, provided that Holders follow the procedures outlined below.
Holders that require assistance with respect to the procedures for participating in the 2023 Put Option should contact the Settlement Agent, the contact details for whom are set out on the last page of this 2023 Put Option Event Notice.
Euroclear and Clearstream, Luxembourg will collect from the Direct Participants:
participate the Notes in the 2023 Put Option and deliver the acceptances held by them on behalf of their Direct Participants; and
credit their accounts on the Settlement Date, in respect to all Notes in respect of which a 2023 Put Option Election Notice has been validly submitted; and
By participating in the 2023 Put Option in this manner, Holders will be deemed to have acknowledged that they have received this 2023 Put Event Notice and agree to be bound by the terms of this 2023 Put Event Notice and that the Issuer may enforce such agreement against such Holders.

Ventas Commences Tender Offers for 2.80% Senior Notes Due 2024 and 4.125% Senior Notes Due 2024

Retrieved on:

Monday, April 3, 2023

See “Full Tender Offer Consideration; Late Tender Offer Consideration; Accrued Interest” in the Offer to Purchase.

Key Points:

See “Full Tender Offer Consideration; Late Tender Offer Consideration; Accrued Interest” in the Offer to Purchase.
Holders of Notes subject to the Offers who validly tender their Notes after the Early Tender Time and before the Expiration Time and whose Notes are accepted for purchase will receive the applicable Late Tender Offer Consideration.
The Early Tender Payment for each Series of Notes is Cdn$30 per Cdn$1,000 principal amount of Notes.
The Late Tender Offer Consideration for the Notes purchased pursuant to the Offers will be calculated by taking the Full Tender Offer Consideration for the applicable Series of Notes and subtracting from it the Early Tender Payment of Cdn$30 per Cdn$1,000 principal amount of Notes.

WeWork Announces Commencement of Exchange Offers and Consent Solicitations for Outstanding 7.875% Senior Notes due 2025 and 5.00% Senior Notes due 2025, Series II

Retrieved on:

Monday, April 3, 2023

No consideration will be paid for Consents in the Consent Solicitations.

Key Points:

No consideration will be paid for Consents in the Consent Solicitations.
Shares of Class A Common Stock delivered as part of the Exchange Consideration will be rounded down to the nearest whole share.
The Company has engaged PJT Partners LP as the dealer manager (the “Dealer Manager”) for the Exchange Offers and Consent Solicitations.
Questions concerning the Exchange Offers and the Consent Solicitations may be directed to the Dealer Manager or the Exchange Agent, in accordance with the contact details shown on the back cover of the Offering Memorandum.